P929: IXAZOMIB AND DARATUMUMAB WITHOUT DEXAMETHASONE (I-DARA) IN ELDERLY FRAIL RELAPSING MYELOMA (RRMM) PATIENTS: RESULTS OF THE PHASE 2 STUDY IFM 2018-02 OF THE INTERGROUPE FRANCOPHONE DU MYELOME (IFM).

• M. Macro,
• C. Touzeau,
• C. Mariette,
• S. Manier,
• S. Brechignac,
• L. Vincent,
• B. Hebraud,
• O. Decaux,
• S. Schulmann,
• C. Lenoir,
• P. Godmer,
• A. Farge,
• L. Peyro Saint Paul,
• J.-J. Parienti,
• X. Leleu

Affiliations

M. Macro

1 HEMATOLOGY IHBN, University Hospital, CAEN

C. Touzeau

2 HEMATOLOGY, University Hospital, Nantes

C. Mariette

3 HEMATOLOGY, University Hospital, Grenoble

S. Manier

4 Hematology, University Hospital, Lille

S. Brechignac

5 Hematology, University Hospital, Paris

L. Vincent

6 Hematology, University Hospital, Montpellier

B. Hebraud

7 Hematology, University Hospital, Toulouse

O. Decaux

8 Hematology, University Hospital, Rennes

S. Schulmann

9 Hematology, University Hospital, Nancy

C. Lenoir

10 Hematology, Private Hospital, Bordeaux

P. Godmer

11 Hematology, Community Hospital, Vannes

A. Farge

12 Hematology

L. Peyro Saint Paul

13 Clinical Research, University Hospital, CAEN

J.-J. Parienti

13 Clinical Research, University Hospital, CAEN

X. Leleu

14 Hematology, University Hospital, Poitiers, France